Stay updated on Alirocumab vs Statin for Neoatherosclerosis Clinical Trial
Sign up to get notified when there's something new on the Alirocumab vs Statin for Neoatherosclerosis Clinical Trial page.

Latest updates to the Alirocumab vs Statin for Neoatherosclerosis Clinical Trial page
- Check6 days agoChange DetectedRevision v3.4.3 was added and revision v3.4.2 was removed from the record history.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedThe page now shows a new 'Revision: v3.4.2' indicator and the previous government funding status notice was removed; these are minor site-wide updates.SummaryDifference0.9%

- Check41 days agoChange DetectedThe page now surfaces a 'Show glossary' option and includes explanations of color-coded changes (green for additions and red for deletions) along with an updated revision note (v3.4.1). The deletions include removing the No FEAR Act data label and the revision version, but there are no changes to core study content, eligibility, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference2%

- Check56 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed from the record history, updating the page's version history; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check70 days agoChange DetectedThe new version adds the last known status and responsible party (Hiromasa Otake, Kobe University) with the date 2018-05, and notes the recruitment status in the study record history.SummaryDifference1.0%

- Check84 days agoChange DetectedRevision history shows a new revision: v3.3.3 was added. The HHS Vulnerability Disclosure link and the v3.3.2 revision note were removed from the footer.SummaryDifference0.2%

Stay in the know with updates to Alirocumab vs Statin for Neoatherosclerosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Alirocumab vs Statin for Neoatherosclerosis Clinical Trial page.